Ann M Graybiel

Plain English
This study investigated how monkeys learn habits and how their brain activity changes during this process. The researchers found that when monkeys formed habits, their brains used less energy to switch between actions, with lower energy needs observed when they repeated similar movements. These findings matter because they help us understand the brain's efficiency during habit formation, which is crucial for developing better treatments for disorders related to habit learning. Who this helps: This helps researchers and clinicians working with patients who have difficulty forming or breaking habits, such as those with addiction or neurodevelopmental disorders.

Plain English
This study examined how different parts of the brain, specifically the orbitofrontal cortex (OFC) and anterior cingulate cortex (ACC), influence decision-making and bodily responses in monkeys. The researchers found that the OFC is responsive to both good and bad choices, while the ACC shows more activity when facing negative outcomes. When the OFC was stimulated, the monkeys avoided negative choices more often, indicating its important role in weighing options during decision-making. Understanding these brain functions could help explain mood disorders. Who this helps: This research benefits patients with mood disorders and their doctors.

Plain English
Researchers studied how certain brain cells in mice affected movement problems caused by the drug levodopa, which is commonly used for Parkinson's disease. They found that the behavior of these brain cells changed in a predictable way during dyskinesia, which is an involuntary movement disorder, and that blocking specific chemical signals improved the drug's benefits while reducing these troubling movements. This matters because it could lead to better treatments for the difficult side effects of levodopa that many patients experience. Who this helps: Patients with Parkinson's disease.

Plain English
This study looked at how a substance called nociceptin orphanin F/Q is affected by stress and how it impacts feelings of reward and motivation. Researchers found that exposure to early-life stress in mice increased nociceptin levels in certain brain areas, and a specific treatment with a nociceptin blocker improved motivation and learning related to rewards in both rats and depressed humans. These findings are important because they suggest that targeting nociceptin could help alleviate symptoms of depression and improve motivation in those affected by chronic stress. Who this helps: This helps patients with depression and their doctors.

Plain English
Researchers examined the brain's basal ganglia, which play a key role in movement, and identified new pathways that affect how movement is controlled. They found that these newly identified pathways can help balance movement signals, especially in conditions like Parkinson's disease. This is important because it could lead to better treatment options for patients suffering from movement disorders. Who this helps: Patients with Parkinson's disease and other movement disorders.

Plain English
The study examined how certain brain areas are affected in a mouse model of Huntington's disease (HD). Researchers found that some important molecules (like PDE10A and dopamine receptors) were significantly lower in a specific brain region known as the striosome in HD mice, while another receptor, mu-opioid, was higher. These findings help us understand why certain neurons in this area are particularly vulnerable in HD, which could aid in developing new treatments. Who this helps: This helps patients with Huntington's disease and their doctors by providing insights into the disease's progression and potential therapies.

Plain English
This study looked at how monkeys learn habits and how their brains work during that process. Researchers found that when monkeys formed habits, their brains used less energy to move between different actions, specifically requiring lower energy for simpler repeated movements. This is important because it helps us understand how the brain organizes and manages the learning of habitual behaviors, which can inform treatments for conditions that affect learning and movement. Who this helps: This research benefits scientists and healthcare professionals studying brain function and rehabilitation therapies for patients with movement disorders.

Plain English
Researchers studied how specific brain cells in mice with Parkinson's disease respond to levodopa, a common treatment that can cause involuntary movements known as dyskinesia. They found that when mice experienced dyskinesia, certain brain cells changed their activity depending on their state, influenced by both dopamine and a different signal. By targeting specific pathways in these cells, they were able to improve the benefits of levodopa while reducing the severity of dyskinesia, showing that there are ways to lessen side effects. Who this helps: This helps patients with Parkinson's disease who experience levodopa-induced dyskinesia.

Plain English
This study examined how stimulating a specific brain area affects decision-making in female primates. The researchers found that when they stimulated the cingulate cortex, it led to a negative decision-making bias, indicating a drop in communication between parts of the brain that control thought and emotion. Specifically, they measured a significant decrease in this communication, suggesting that this disruption could explain the negative outlook often seen in people with depression. Who this helps: This helps patients with depression and their doctors by providing insights into how brain communication might influence emotional decision-making.

Plain English
This study looked at how a specific neuropeptide called nociceptin influences the brain's dopamine system, especially in areas that control movement and behavior. Researchers found that a certain type of cell in the striatum, which is involved with dopamine signaling, shows a distinct pattern of nociceptin expression, specifically in a subregion known as striosomes. This is important because it sheds light on how the brain's wiring develops and functions, which could have implications for understanding movement disorders or behavioral issues. Who this helps: This helps researchers and clinicians working with patients who have movement disorders or psychiatric conditions.

Plain English
This study looked at how certain brain cells in mice help coordinate complex movements, like stepping in a wheel with different foothold pegs. Researchers found that a specific group of brain cells in the striatum react strongly to certain patterns in these movements, while other brain areas showed less activity related to this type of coordination. Understanding how these cells respond to movement patterns could help explain why Parkinson's patients often need rhythmic cues to move effectively. Who this helps: This helps patients with movement disorders, especially those with Parkinson's disease.

Plain English
This study looked at how different pathways in the brain affect movement and behavior by examining specific neurons that produce dopamine. Researchers found that two new pathways from a brain region called the striosome influence movement in opposite ways: one inhibits movement while the other excites it. Understanding these pathways is important because it could change how we think about and treat conditions related to movement and motivation, such as Parkinson's disease. Who this helps: This helps patients with movement disorders and their doctors.

Plain English
This study looked at how dopamine, a key brain chemical, interacts with nerve signals in monkeys. The researchers developed new methods to measure both dopamine levels and nerve spikes at the same time, achieving an impressive accuracy rate of about 84.5% in identifying these signals. Understanding this relationship is important because it could help clarify how brain circuits work in both healthy and diseased states. Who this helps: This helps researchers and healthcare providers better understand brain functioning and can improve treatments for neurological disorders.

Plain English
This research studied how dopamine, a chemical in the brain linked to learning and rewards, was released in different areas of the brain (specifically, the dorsal striatum) as mice learned tasks involving visual cues and rewards. The scientists found that the pattern of dopamine release varied depending on the brain area; for example, one area showed quick spikes in response to cues, while another showed a more steady release. These results challenge traditional ideas about how dopamine signals predict rewards and suggest we need to rethink how we understand learning in the brain. Who this helps: This helps researchers and clinicians understand how learning and reward signaling work, potentially aiding in the development of treatments for conditions like addiction or Parkinson's disease.

Plain English
This study looked at how two specific pathways in the brain—called D1 and D2 pathways—affect movement and behavior through a different area of the brain known as the striosome. Researchers found that these striosome pathways act differently: the S-D1 pathway slows down dopamine activity while the S-D2 pathway speeds it up. This research is important because it changes our understanding of how brain circuits work together to control movement and could lead to new treatments for movement and mental health disorders. Who this helps: This helps patients with movement disorders and healthcare providers by offering new insights for treatment strategies.

Plain English
This study looked at a protein called LRRK2, which is linked to Parkinson's disease, particularly how it is regulated by another protein named CalDAG-GEFI (CDGI). Researchers found that CDGI helps LRRK2 switch between two forms, which is important for LRRK2’s role in cell function and neurodegeneration. Understanding this relationship between CDGI and LRRK2 could open new pathways for treatments, focusing not just on inhibiting LRRK2's kinase activity but also on its GTPase regulation. Who this helps: This benefits patients with Parkinson's disease and researchers developing new therapies.

Plain English
This study looked at how a specific neuropeptide system, called nociceptin, affects dopamine signaling in parts of the brain. Researchers found that nociceptin is mainly expressed in special clusters within the striatum, particularly in regions containing dopamine neurons, suggesting that it plays a key role in how these neurons communicate. Understanding this relationship is important because it could lead to new insights into brain development and the functioning of circuits that are essential for behavior and cognition. Who this helps: This helps patients with conditions related to dopamine signaling, such as Parkinson's disease or addiction.

Plain English
This study looked at specific types of brain cells that are damaged in Huntington's disease (HD), particularly focusing on two important ways these cells are organized. Researchers found that in human patients, a certain type of neuron (the striosomal indirect-pathway neurons) was significantly reduced, while in mouse models, the differences between neuron types were less clear, especially in later stages of the disease. This matters because understanding how these brain cells are affected can lead to better treatment approaches tailored for different stages of HD. Who this helps: This helps patients with Huntington's disease and their doctors by providing insights for developing targeted therapies.

Plain English
This study examined how certain cells and structures in the human brain's dorsal striatum, an area involved in mood and movement, are organized and function. Researchers found that a protein called DARPP-32 is mainly located in specific areas called striosomes, particularly in the caudate nucleus, while its presence in the surrounding matrix is much lower. These findings are important because they could help us understand how different parts of the brain communicate and may influence treatments for conditions affecting mood and movement, like Parkinson's disease. Who this helps: This helps patients with movement disorders and other neurological conditions.

Plain English
This study looked at specialized areas in the brain called striosomes and their surrounding structures, matrisomes, to understand how they help connect our thoughts with our actions. Researchers found that striosomes can regulate dopamine neurons, important for motivation, and play a role in learning from rewards and making decisions based on feelings. These findings are significant because they might help explain how some brain functions are disrupted in mental health issues like depression and anxiety. Who this helps: This helps patients with neuropsychiatric conditions and their doctors.

Plain English
Researchers created a flexible thread-like tool made from carbon fiber to measure dopamine activity in different parts of the brains of rats. This new tool can reach up to 16 target areas from a single entry point, allowing for better monitoring of brain activity. They found that their tool effectively recorded dopamine changes in the brain, paving the way for new insights into brain function and improvements in treating conditions like Parkinson's disease and mood disorders. Who this helps: This benefits patients with neurological diseases, their doctors, and researchers in brain science.

Plain English
This study examined how a specific genetic mutation in the FOXP2 gene affects brain cells involved in speech and language. Researchers found that this mutation disrupts certain protein motors in brain cells, leading to issues with cell function and vocalization in mice. By reducing the levels of the problematic proteins, they were able to improve both the brain cell function and vocal abilities in the mice. Who this helps: This helps patients with speech disorders linked to FOXP2 mutations.

Plain English
This study looked at how mice learn to move by breaking down complex stepping patterns into manageable parts, known as "chunks." The researchers found that when mice performed these chunks, their movements became more consistent and rhythmic, with specific patterns in how their limbs moved together. This understanding could help improve training methods for motor skills in various animals, including humans, by simplifying complex movements into easier-to-learn sequences. Who this helps: This benefits patients working on rehabilitation and recovery from movement-related injuries.

Plain English
This study looked at how dopamine, a brain chemical linked to learning and rewards, changes in different parts of the striatum (a brain area) as mice learned to associate visual cues with rewards. Researchers found that the way dopamine responded varied between the medial and lateral areas of the striatum and that these responses didn't fit the usual models of learning based on reward signals. For example, in the medial area, dopamine responses to rewards were low initially, while in the lateral area, there were strong dopamine releases both when the cues appeared and when the rewards were given, especially when the mice had to make discriminative choices. Who this helps: This research helps scientists and researchers understand the complexities of how the brain processes rewards, which can lead to better treatments for conditions involving learning and motivation.

Plain English
Researchers created a new type of tiny, flexible sensor made from carbon fiber that can measure dopamine levels in different areas of the brain through a single entry point. This new sensor can reach up to 16 different locations in the brain and allows for a broader, more effective way to study brain activity. Their tests showed that this technology could improve our understanding of how brain chemicals affect conditions like Parkinson's disease and mood disorders. Who this helps: This helps patients with neurological disorders, as well as the doctors treating them.

Plain English
This study looked at how certain brain cells in mice help coordinate complex movements by responding to the rhythms of those movements. Researchers found that specific brain cells in the striatum reacted to combinations of factors like timing and the synchronization of different body parts during movement. They discovered that these rhythm-sensitive cells could improve our understanding of movement problems in diseases like Parkinson's. Who this helps: This research benefits patients with movement disorders, such as those with Parkinson's disease.

Plain English
Researchers studied how dopamine levels and brain cell activity interact while a monkey performed a task. They developed a new method to measure both dopamine and brain signals at the same time, achieving an impressive accuracy rate of 84.5% in identifying brain spikes. Understanding this relationship is important because it could help us learn more about how the brain controls behavior, which has implications for treating neurological disorders. Who this helps: This benefits patients with neurological conditions and their doctors.

Plain English
This study explored how a specific part of the brain called the right dorsolateral prefrontal cortex (r-dlPFC) affects our ability to make decisions when we face choices that have both positive (reward) and negative (punishment) outcomes. Researchers found that when they disrupted the r-dlPFC, people's sensitivity to rewards decreased, meaning they were less motivated to approach positive options. This research is important because it improves our understanding of how brain functions relate to decision-making, which could lead to new treatments for mental health issues related to avoidance behaviors. Who this helps: This helps patients with anxiety or depression who struggle with decision-making.

Plain English
This study looked at how a drug called VU0152099 affects the choice between cocaine and food in male rats. Researchers found that the drug consistently reduced the rats' preference for cocaine over time, without causing a rebound effect after treatment ended. These results indicate that drugs targeting specific brain receptors could be effective for treating cocaine addiction. Who this helps: This research benefits patients struggling with cocaine use disorder.

Plain English
This study looked at how mice learn to connect their actions to both rewards and punishments using a new testing method. Researchers found that certain brain cells (called striosomal neurons) were especially good at tracking both positive and negative outcomes, sometimes even within the same cell. They discovered that these brain cells were better at recognizing when rewards or punishments were bigger than expected. Who this helps: This research benefits neuroscientists and psychologists looking to understand decision-making in humans and animals.

Plain English
This study looked at how Cannabinoid Receptor 1 (CB1R) affects brain development in newborns, focusing on connections between nerve cells in the brain. Researchers found that CB1R starts working between 5 to 7 days after birth, helping to organize important brain structures that influence dopamine activity. In mice without CB1R, these structures were disorganized by 11 days old, highlighting a key role for CB1R in brain wiring that lasts into adulthood and raising concerns about how the use of marijuana or certain medications by breastfeeding mothers could affect brain development in their babies. Who this helps: This helps parents, doctors, and researchers focused on infant brain health.

Plain English
This study looked at how drug use, specifically amphetamines, affects brain changes in mice and leads to repetitive behaviors. Researchers found that certain gene changes occurred in the brains of mice showing these behaviors, particularly in a group that reacted strongly to the drugs, with 20 unique genes being affected. This matters because it highlights a potential biological link between drug use and disorders like schizophrenia and autism, suggesting that these changes in gene activity could play a role in making some people more vulnerable to these conditions. Who this helps: This helps researchers and doctors understand the relationship between drug use and mental health disorders.

Plain English
This study examined how people with major depressive disorder (MDD) make decisions, especially when it comes to choosing between pursuing rewards or avoiding negative outcomes. Researchers found that those with MDD were less responsive to potential rewards and showed a tendency to avoid taking risks, as reflected by their brain activity. Specifically, they had a significantly lower sensitivity to rewards and different brain responses when compared to healthy individuals. Who this helps: This benefits patients with major depressive disorder and their healthcare providers.

Plain English
This study looked at how specific areas of the brain in macaque monkeys influence decision-making, particularly making them more pessimistic, which is linked to anxiety. By stimulating certain brain regions, researchers found that monkeys were more likely to avoid choices, indicating an anxiety-like state, and identified key areas involved in this process, such as the pregenual anterior cingulate cortex and the caudal orbitofrontal cortex. These results highlight the brain's interconnected networks that may play a role in anxiety disorders, showing how some brain areas can lead to more cautious decision-making. Who this helps: This helps researchers and clinicians working with patients suffering from anxiety disorders.

Plain English
This study focused on a protein called CalDAG-GEFI (CDGI) that plays an important role in how certain brain cells work, particularly in the striatum, which is involved in movement and behavior. The researchers found that when CDGI was removed in mice, it led to problems with how these brain cells communicated and made it harder for the animals to learn sequences properly. Additionally, the mice showed increased repetitive behaviors and less control over drug-seeking actions, pointing to CDGI's important role in movement disorders like Huntington's disease and Parkinson's disease. Who this helps: This research benefits patients with movement disorders and their doctors by highlighting a potential target for new treatments.

Plain English
This study looked at how small electrical pulses in a specific part of the brain can influence decision-making, specifically leading monkeys to avoid certain choices that might be seen as risky. When researchers stimulated the pregenual anterior cingulate cortex (pACC), the monkeys showed a 20% increase in avoidance decisions during tasks that had both good and bad options presented together. The results matter because they help us understand the brain circuits involved in emotional decision-making, particularly in situations where there is conflicting information about potential risks and rewards. Who this helps: This benefits researchers and clinicians studying decision-making and emotional behavior in patients.

Plain English
This research studied how a specific part of a gene, called a microexon, is spliced in neurons, which affects how nerve cells develop and function. The researchers found that a particular splicing factor, SRRM4/nSR100, helps include this microexon in a form of mRNA that is unique to neurons, which is crucial for creating a protein that helps regulate gene expression in brain cells. This work is important because understanding this process could lead to better insights into brain development and possibly pave the way for treatments related to neurological disorders. Who this helps: This helps patients with neurological disorders and the doctors who treat them.

Plain English
This study looked at how decision-making differs between people with major depressive disorder (MDD) and healthy individuals, using brain scans to measure activity in specific regions. It involved 42 female participants, with 18 having MDD, and found that those with MDD showed unusual brain activity in areas linked to evaluating choices—specifically, the anterior cingulate cortex and other related areas—as they faced decisions about approaching or avoiding certain situations. This is important because understanding these brain changes can help identify new ways to diagnose and treat depression. Who this helps: This research benefits patients with major depressive disorder and their doctors.

Plain English
This study looked at how certain brain activities in the caudate nucleus of monkeys are linked to their decisions when faced with choices that have both good and bad aspects. The researchers found that 98.4% of brain responses in the beta frequency range positively correlated with the value of the choice made, while 95.8% of these responses were also connected to mistakes made during the task. These findings are important because they help us understand how the brain processes emotions related to decision-making and can inform treatments for conditions that involve decision-making difficulties. Who this helps: This helps patients with decision-making disorders and their doctors.

Plain English
This study looked at a new way to deliver drugs directly to specific parts of the brain, which is important for treating neurological diseases. Researchers created a method using advanced computer mapping to guide the delivery of multiple small doses, leading to nearly complete coverage of the target areas in rodents with only a 5% error rate when tested. This is significant because it improves the effectiveness of treatments while reducing harmful side effects. Who this helps: This benefits patients with neurological disorders.

Plain English
This study looked at specific brain cells called striatal projection neurons (SPNs) in mice and how their development affects the organization of certain brain circuits linked to movement and behavior. Researchers found that even though these neurons come from the same source, the timing of their birth influences where their connections go in the brain and how they work together. This is important because it helps us understand the brain's wiring and could shed light on conditions like Parkinson's disease. Who this helps: Patients with movement disorders and neurologists.

Plain English
Researchers studied a new type of probe called a concentric marking electrode (CME) designed to both record brain activity and leave small marks in the brain tissue. They tested this probe in the CA3 area of the hippocampus in adult rats and found that it could create tiny iron deposits, as small as 100 micrometers, which were stable for up to 10 months, allowing for precise tracking of brain regions using MRI. This method improves accuracy in studying brain functions and understanding specific areas better, which is important for advancing neurological research and treatments. Who this helps: This benefits researchers and clinicians working in neuroscience and brain health.

Plain English
Researchers studied the relationship between dopamine levels and beta-band brain activity in monkeys to better understand motor control and rewards in Parkinson's disease. They found that while dopamine and beta activity generally follow an expected pattern, there are specific situations where they can move together instead of opposing each other. This new understanding can lead to better ways to diagnose and treat Parkinson's disease and other similar disorders. Who this helps: This helps patients with Parkinson's disease and their doctors.

Plain English
This study focused on developing a new tool for collecting and analyzing brain fluid, which helps in understanding various brain diseases. The researchers created a small device that can gather tiny amounts of brain fluid to measure important molecules like proteins, improving on previous methods that couldn't capture these components well. Their device works better than earlier models by controlling fluid flow more precisely and collecting less waste, which enables better analysis of brain health. Who this helps: This benefits researchers and doctors studying brain disorders.

Plain English
Dr. Oleh Hornykiewicz made major discoveries in the 1960s about Parkinson's disease, specifically that a lack of dopamine in the brain causes many symptoms of the disease. He also found that giving patients levodopa helped relieve these symptoms, which has positively impacted millions of lives. His work opened up a new field of research about how dopamine affects behavior and set the stage for better treatments for those affected by neurological disorders. Who this helps: Patients with Parkinson's disease and their caregivers.

Plain English
This study looked at how specific brain areas help mice learn to differentiate between good and bad choices. Researchers found that a part of the brain called the striosome is crucial for this kind of learning; specifically, aging and a model of Huntington's disease disrupted this function significantly. This matters because understanding these processes can help develop better treatments for learning difficulties in older adults and people with Huntington's disease. Who this helps: This research benefits patients with Huntington's disease and older adults experiencing cognitive decline.

Plain English
This study looked at how dopamine affects two types of brain areas, called striosomes and matrix, in a part of the brain known as the striatum. Researchers found that when dopamine is released, it makes the activity in the matrix last longer for certain neurons, but it shortens activity in the striosomes. Specifically, dopamine extended the "upstate" (a time when neurons are more active) in matrix neurons by regulating their activity through a specific mechanism. Who this helps: This research helps scientists and doctors understand how dopamine influences brain function and could lead to better treatments for conditions related to dopamine, like Parkinson's disease.

Plain English
This study looked at a specific receptor called mu-opioid receptor 1 (MOR1) in a mouse model of Huntington's disease (HD) as they aged from 3 to 19 months. The researchers found that while many markers for certain brain compartments decreased, MOR1 actually increased in the striatum, especially at the back of the brain, as the mice got older and more sick. This is important because it could help us understand psychiatric symptoms in HD, such as depression and abnormal movements. Who this helps: Patients with Huntington's disease and their doctors.

Plain English
Researchers developed tiny, flexible probes called S-MINIs that deliver medication directly to hard-to-reach areas in the brain. These probes are 3.5 times better at preventing scar tissue from forming compared to older implants, and they can accurately target deep brain structures with an average error of just 0.23 mm. This advancement is important because it minimizes damage during procedures and improves treatment effectiveness for neurological conditions. Who this helps: This helps patients with brain disorders who need targeted drug delivery.